Saatchi Picks Up $150 Mil. in Novartis Work

NEW YORK Publicis Groupe’s Saatchi & Saatchi has landed on Novartis’ global roster, picking up creative duties on four non-prescription brands after a shootout involving roster and non-roster shops, sources said. The brands, which are marketed by Novartis’ consumer health division, are TheraFlu, Triaminic, Voltaren and Otrivin, according to an agency memo obtained by Adweek.

The assignments, which carry estimated billings of $150 million, were the result of a series of meetings between Saatchi and client executives that began in June, said sources.